News

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced 24-hour systolic blood pressure in individuals with uncontrolled and treatment-resistant hypertension, according to ...
Investigating genetic variations in the vitamin D receptor (VDR) gene has revealed inconsistent associations with ...
With proper treatment, regular monitoring, and commitment to lifestyle changes, many patients with heart failure can lead ...